NCT03729752View on ClinicalTrials.gov

PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

October 31, 2026

Study Completion Date

December 1, 2026

Conditions
HIV-1-infection
Interventions
DRUG

[89]Zr-DFO-VRC-HIVMAB060-00-AB

Radiolabeled monoclonal antibody that targets the envelope protein of HIV-1.

Trial Locations (1)

94110

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

amfAR, The Foundation for AIDS Research

OTHER

lead

University of California, San Francisco

OTHER